- Home
- SOPA vs ADIL Comparison
SOPA vs ADIL Comparison
Compare SOPA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- ADIL
- Stock Information
- Founded
- SOPA 2018
- ADIL 2010
- Country
- SOPA Singapore
- ADIL United States
- Employees
- SOPA N/A
- ADIL N/A
- Industry
- SOPA EDP Services
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- ADIL Health Care
- Exchange
- SOPA Nasdaq
- ADIL Nasdaq
- Market Cap
- SOPA 7.3M
- ADIL 7.7M
- IPO Year
- SOPA 2021
- ADIL 2018
- Fundamental
- Price
- SOPA $1.26
- ADIL $0.32
- Analyst Decision
- SOPA Strong Buy
- ADIL Strong Buy
- Analyst Count
- SOPA 1
- ADIL 1
- Target Price
- SOPA $18.00
- ADIL $1.50
- AVG Volume (30 Days)
- SOPA 136.3K
- ADIL 420.1K
- Earning Date
- SOPA 11-14-2025
- ADIL 11-13-2025
- Dividend Yield
- SOPA N/A
- ADIL N/A
- EPS Growth
- SOPA N/A
- ADIL N/A
- EPS
- SOPA N/A
- ADIL N/A
- Revenue
- SOPA $7,227,427.00
- ADIL N/A
- Revenue This Year
- SOPA $26.32
- ADIL N/A
- Revenue Next Year
- SOPA $13.64
- ADIL N/A
- P/E Ratio
- SOPA N/A
- ADIL N/A
- Revenue Growth
- SOPA 4.65
- ADIL N/A
- 52 Week Low
- SOPA $0.64
- ADIL $0.22
- 52 Week High
- SOPA $6.75
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- SOPA 35.23
- ADIL 44.42
- Support Level
- SOPA $1.20
- ADIL $0.28
- Resistance Level
- SOPA $1.55
- ADIL $0.33
- Average True Range (ATR)
- SOPA 0.19
- ADIL 0.02
- MACD
- SOPA -0.07
- ADIL -0.00
- Stochastic Oscillator
- SOPA 5.52
- ADIL 52.84
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.